- $138.44bn
- $190.12bn
- $62.58bn
Street View: Pfizer lung cancer drug miss a setback, but hopes persist in earlier treatment
Pfizer's experimental drug misses main goal of lung cancer trial (updated)
Pfizer's experimental drug misses main goal of lung cancer trial
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Brief: CMA Says Court Of Appeal Ruled Tribunal Was "Wrong To Set Aside Decision" In Relation To Investigation Into Phenytoin
Germany's Merz says current EU budget proposals unaffordable
US health department proposes testosterone therapy label updates (updated)
U.S. STOCKS ON THE MOVE-Kardigan, Energy companies, Take-Two, Accenture
Brief: Pfizer Reaffirms FY2026 Guidance Following CFO Transition Announcement
U.S. STOCKS ON THE MOVE-Kardigan, Energy companies
U.S. STOCKS ON THE MOVE-Pfizer, Accenture, Kroger
Pfizer falls as CFO Dave Denton prepares to step down
Pfizer CFO Dave Denton to leave company in August (updated)
Pfizer CFO Dave Denton to step down in August
Analysis: Big pharma taps UK playbook to pressure European capitals on drug prices
SoftBank Vision Fund CFO is leaving company, memo shows
SoftBank Vision Fund CFO is leaving company, memo shows
Factbox: Global drugmakers invest billions to boost US presence
Brief: Sinopharm Establishes Strategic Partnership With Pfizer